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OBJECTIVES The purpose of this study was to determine the effect of volume overload hypertrophy in the
newborn heart on the cardiac enzymes controlling fatty acid metabolism.
BACKGROUND Shortly after birth, a rise in 59-adenosine monophosphate–activated protein kinase (AMPK)
activity results in the phosphorylation and inhibition of acetyl coenzyme A (CoA) carboxylase
(ACC), and a decline in myocardial malonyl CoA levels with increased fatty acid oxidation
rates. Whether the early onset of hypertrophy in the newborn heart alters this maturational
increase in fatty acid oxidation is unknown.
METHODS Newborn piglets underwent endovascular stenting of the ductus arteriosus on day 1 of life
with a 4.5-mm diameter stent, resulting in a left to right shunt, and left ventricular (LV)
volume loading. Left ventricular and right ventricular samples from fetal, newborn, three-
week control and three-week stented animals were compared.
RESULTS Stenting resulted in echocardiographic evidence of volume overload and myocardial hyper-
trophy. In control animals, left ventricular ACC activity declined from 274 6 30 pmol/mg/
min on day 1 to 115 6 12 after three weeks (p , 0.05), but did not display this maturation
drop in hypertrophied hearts, remaining elevated (270 6 50 pmol/mg/min, p , 0.05). At
three weeks, malonyl CoA levels remained 2.8-fold higher in hypertrophied hearts than in
control hearts. In control hearts, LV AMPK activity increased 178% between day 1 and three
weeks, whereas in hypertrophied hearts AMPK activity at three weeks was only 71% of
control values, due to a significant decrease in expression of the catalytic subunit of AMPK.
CONCLUSIONS Early onset LV volume overload with hypertrophy results in a delay in the normal maturation
of fatty acid oxidation in the newborn heart. (J Am Coll Cardiol 1999;33:1724–34) © 1999
by the American College of Cardiology
Fatty acid oxidation in the heart is a tightly regulated
pathway. A key enzyme involved in fatty acid oxidation is
carnitine palmitoyltransferase-1, which is located on the
outer mitochondrial membrane, and acts as the rate-
limiting step for mitochondrial fatty acid uptake (1). Car-
nitine palmitoyltransferase-1 is in turn regulated by two
important cytoplasmic enzymes, 59-adenosine monophos-
phate (AMP)–activated protein kinase (AMPK) and acetyl
coenzyme A (CoA) carboxylase (ACC) (2). If activated,
AMPK phosphorylates and inhibits ACC, resulting in a
decrease in cytoplasmic levels of malonyl CoA (the product
of ACC). In heart muscle, malonyl CoA is a very potent
inhibitor of carnitine palmitoyltransferase-1 (3). As a result,
an increase in cardiac AMPK activity decreases ACC
activity, decreases cytoplasmic malonyl CoA levels and
increases fatty acid oxidation rates (Fig. 1). In support of
this, studies from our laboratory have observed a good
correlation between AMPK activity, ACC activity, malonyl
CoA levels and fatty acid oxidation rates in the heart (2–4).
In the fetal heart, glycolysis and lactate oxidation are the
primary energy sources (5), and fatty acid oxidation rates are
very low (5). Shortly after birth a dramatic “maturational”
shift occurs, with fatty acid oxidation increasing such that it
becomes the primary source of adenosine triphosphate
production (6–8). These changes as well as the general
control mechanism described above are summarized dia-
grammatically in Figure 1.
We have recently shown in newborn rabbits that the shift
in fatty acid oxidation after birth is associated with an
increase in AMPK expression and activity, a decrease in
ACC activity and a dramatic drop in myocardial malonyl
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CoA levels (4). However, these findings have not yet been
substantiated in a larger animal model, and as yet there are
no data regarding possible differences between right and left
ventricular activity of these enzymes.
In the adult heart, development of ventricular hypertro-
phy results in a decrease in fatty acid metabolism (9) and an
increased reliance on glycolysis as a source of energy (10).
This metabolic shift may represent a regression of metabo-
lism to the newborn profile of energy substrate preference in
the mature heart. Myocardial hypertrophy can also occur in
the newborn, in the clinical situation of volume overload
secondary to congenital defects of the heart and great vessels
(commonly ventricular or atrial septal defects, persistent
patency of the arterial duct and many other more complex
anomalies) (11). Since hypertrophy in the adult heart reverts
metabolism toward the fetal profile, the question arises as to
whether the usual maturational increase in fatty acid oxida-
tion is delayed in the hypertrophied newborn heart. This has
potential clinical significance, since energy substrate prefer-
ence by the heart can influence the outcome of ischemic
injury (2), and the hypertrophied newborn heart may well be
subjected to ischemia during surgery to correct the under-
lying defect.
In this study we determined whether the previously
observed changes in ACC and AMPK activity observed in
Abbreviations and Acronyms
ACC 5 acetyl coenzyme A carboxylase
AMP 5 adenosine monophosphate
AMPK 5 59 adenosine monophosphate–activated protein
kinase
CoA 5 coenzyme A
LV 5 left ventricular
PEG 5 polyethylene glycol
RV 5 right ventricular
Figure 1. Changes in energy balance and fatty acid oxidation in the newborn heart. Dominant pathways are indicated by darker typeface,
and bold arrows; those indicated in gray are diminished. The inner mitochondrial membrane has been omitted for clarity. ACC 5 acetyl
CoA carboxylase; AMP 5 adenosine monophosphate; AMPK 5 59-AMP–activated protein kinase; ATP 5 adenosine triphosphate;
CAT 5 carnitine acyl transferase; CoA 5 coenzyme A; CoASH 5 uncombined CoA; CPT 1 5 carnitine palmitoyl transferase-1; Pi 5
inorganic phosphate; TCA 5 tricarboxylic acid. After birth, a fall in plasma insulin (which is an inhibitor of AMPK expression) levels,
together with a decrease in available glucose and lactate substrate lead to a rise in AMPK activity. 59-Adenosine monophosphate–activated
protein kinase phosphorylates and inactivates ACC, resulting in a decrease in malonyl CoA production. Malonyl CoA in turn has a key
role in inhibiting the activity of CPT 1, the rate limiting translocating protein which allows acylated long chain fatty acids to enter the
mitochondrion. Thus the heart is prepared to utilize fatty acids in the postnatal period, as the level of malonyl CoA, the inhibitor effect
of CPT 1, is greatly reduced. With the onset of suckling, a pronounced rise in plasma fatty acid levels, together with these low levels of
malonyl CoA, facilitate the influx of fatty acyl CoA into the mitochondrion, and an increase in beta-oxidation occurs. Glycolysis and
lactate oxidation, both important pathways in fetal life, decline in their relative contribution as energy sources in the newborn heart.
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the newborn rabbit also occurred in the newborn pig heart.
We also evaluated the consequences of volume overload–
induced myocardial hypertrophy on these enzymes, utilizing
a model of volume overload hypertrophy of the newborn
piglet heart developed in our laboratory.
METHODS
Animal procedures. All animal procedures were performed
under conditions approved by the institutional bioethics
committee in accordance with the published standards of
the Canadian Council on Animal Care. Invasive or imaging
procedures were conducted under general inhalational an-
esthesia using halothane and a 50% O2/N2O mixture. This
choice of anesthetic agent was made because of the ease
with which it could be titrated to attain the desired plane of
anesthesia. Owing to the cardiodepressant properties of
halothane, echocardiographic studies were performed at a
minimal dose (0.1%) with the animals breathing spontane-
ously. There are no reports of any specific effect of these
anesthetic agents on any of the regulatory enzymes assayed
in this study.
FETAL PIGLETS. Yorkshire White sows in late gestation
(126 days) were obtained from local commercial suppliers.
Fetal piglets were harvested from these late gestation sows
anesthetized with a 1% halothane and 50% O2/N2O mix-
ture. The uterine follicles were accessed via a lower abdom-
inal incision and opened, and the fetus was delivered. In situ
removal of the heart and thoracic aorta was rapidly per-
formed via a left lateral thoracotomy without any ventilatory
activity occurring. Umbilical cord blood pH and O2 satu-
ration was determined to exclude hypoxia or acidemia (data
not shown). Rapid dissection of the left ventricular (LV)
and right ventricular (RV) free walls (as described in the
following section) was performed, and these were immedi-
ately frozen in liquid N2 for later tissue analysis.
NEWBORN PIGLETS. On day 1 of life a cohort of normal
newborn piglets was sacrificed, and left and right ventricular
free walls were excised en bloc. This was performed via a left
lateral thoracotomy with the animal deeply anesthetized.
The pericardial sac was opened, and a 18-gauge cannula was
introduced into the main pulmonary artery. The intravas-
cular volume was rapidly depleted for 30 s at 40 mm Hg
negative pressure. The heart was then mobilized by rapid
transection of the vascular pedicles, and delivered from the
thorax. While still contracting, the LV free wall was
dissected by incising at the left atrioventricular groove
leftward of the left anterior descending coronary artery, and
following the septal demarcation to the posterior atrioven-
tricular groove. The right ventricular free wall was similarly
mobilized. The left and right ventricular free wall tissue
sections were freeze clamped in liquid N2 within 90 s of
pulmonary arterial cannulation.
LEFT TO RIGHT SHUNT IN THE NEWBORN PIGLET. A left to
right shunt at systemic pressure was created in newborn
piglets from day 1 of life by inserting a 4.5-mm diameter
end-arterial stent (Palmaz-Schatz coronary arterial stent,
Johnson and Johnson, New Brunswick, New Jersey) in
the ductus arteriosus. The stent was deployed via a 5-F
4.5 mm 3 2 cm balloon angioplasty catheter (Numed). The
procedure was performed under fluoroscopic guidance on
the anesthetized animal using a transvenous approach via
the right external jugular vein, which was accessed using the
Seldinger technique from a cervical incision. After the
procedure the incision was sutured, and the animal received
a single parenteral 50-mg dose of ampicillin, and was
allowed to recover and then rejoin its mother. In the
experimental series three of the control piglets were “sham
catheterized,” and the rest were not subjected to any
procedure. After the stent insertion or sham procedure, the
animals suckled ad libitum from the sow, and their nutri-
tional state was determined by daily weighing. No animal
was subjected to any period of fasting before sacrifice, as
significant calorie deprivation has previously been found to
alter ACC expression and activity in rats.
MODEL CHARACTERIZATION. The hemodynamic charac-
teristics of this model have previously been detailed in our
laboratory by Coe et al. (unpublished data). Piglets with a
4.5-mm stent, studied after 2 weeks of life under general
anesthesia manifested a ratio of pulmonary to systemic
blood flow of 1.75:1 by indocyanine green indicator dilution
methods as previously described by Krovetz and Gessner
(12). Stented animal weight, heart rate and respiratory rate
were similar to those recorded in this study, and RV/LV
systolic pressure ratio increased from 40% to 60%. Prelim-
inary echocardiographic studies performed on these animals
had revealed increasing LV end-diastolic dimensions con-
sistent with LV volume loading.
Animals in this cohort were identical to those character-
ized previously in all respects except that they underwent no
invasive hemodynamic studies. Transthoracic echocardio-
graphic assessment was performed in these animals using a
two-dimensional/Doppler echocardiographic system
(Hewlett-Packard, Boston, Massachusetts), and standard
imaging planes were employed. Each control animal and
each stented piglet was studied at 3 weeks of age under light
inhalational anesthesia (0.1% halothane and 50% O2/N2O
mixture), breathing spontaneously. Heart rate and respira-
tory rate were recorded. Echocardiographic determination
of LV mass, volumes and ejection were made from two-
dimensional biplane subcostal images (using the modified
Simpson’s rule) (13) as well as from M-mode traces (using
the Devereux modification of the Penn convention) (14)
using an on-line software package.
These control and stented animals were then sacrificed
immediately after echocardiographic assessment, under
deep anesthesia as described above. Left and right ventric-
ular tissues were harvested for further analysis.
Tissue analysis. MATERIALS. Acetyl CoA was obtained
from Boehringer-Mannheim. The synthetic peptide with
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the sequence HMRSAMSGLHLVKRR (SAMS peptide)
used in the AMPK assay was synthesized by the Alberta
Peptide Institute (Edmonton, Canada). [32P]-Adenosine
triphosphate, and NaH[14C]O3 were obtained from ICN
Radiopharmaceuticals. Peroxidase-labeled Streptavidin was
purchased from Mandel Scientific (Guelph, Canada).
Trans-blot nitrocellulose membrane was obtained from
Bio-Rad (Hercules, California). ECL Western Blotting
detection kits were purchased from Amersham Interna-
tional (Princeton, New Jersey). Autoradiographic film was
purchased from Eastman-Kodak (Rochester, New York).
All other reagents and chemicals were purchased from the
Sigma Chemical (St. Louis, Missouri).
BIOCHEMICAL ASSAYS. Biochemical analysis of myocardial
ACC and AMPK activity were performed on 6% polyeth-
ylene glycol (PEG) 6000 precipitates of homogenized ven-
tricular myocardium, as described in detail previously (15).
Acetyl CoA carboxylase was measured using a [14C]O2
fixation assay, which measured the production of [14C]
malonyl CoA under basal conditions, and during maximal
stimulation in the presence of 10 mmol citrate, as described
by Witters and Kemp (16). 59-Adenosine monophosphate–
activated protein kinase was measured by following incor-
poration of 32P from [32P]-adenosine triphosphate into a
synthetic peptide with the sequence HMRSAMS-
GLHLVKRR, as previously described (4). Malonyl CoA
and other CoA esters were extracted using a 6% perchloric
acid protocol (17) and measured using a modified high
performance liquid chromatography procedure described by
King et al. (3,18) and detailed previously (3).
WESTERN ANALYSES. Western immunoblots of ACC and
AMPK protein were performed on all 6% PEG precipitates.
Acetyl CoA carboxylase and AMPK proteins were sepa-
rated by electrophoresis of 25-mg samples on 6% and 9%
sodium dodecyl sulfate–polyacrylamide gels respectively,
and then electrotransferred to nitrocellulose membranes.
These were blocked with 10% (wt/vol) milk in phosphate-
buffered saline. Acetyl CoA carboxylase blots were probed
with peroxidase-labeled Streptavidin (which binds biotin-
containing groups of carboxylases); AMPK blots were
probed with anti-alpha-2 subunit AMPK monoclonal an-
tibodies (a generous gift of Dr. G. Hardie, Dundee, United
Kingdom). The AMPK antibody was then detected using a
secondary antibody–peroxidase-linked chemiluminescent
labeling for band identification. Digitally scanned autora-
diographs were quantified using Imagequant software (Mo-
lecular Dynamics, Sunnyvale, California).
Statistical analysis. Data are expressed as group means 6
SEM. Cardiac morphometric data are presented both as
uncorrected values, and indexed to animal weight. Statistical
significance is expressed at the p , 0.05 level, as determined
by a one-way analysis of variance with the Neuman-Keuls
post hoc test for specific group comparisons, except in the
case of Table 1, where Student t test of population means
for two individual groups was applied.
RESULTS
The effect of ductus arteriosus stenting on cardiac indi-
ces. In the newborn period, the left ventricle assumes the
task of systemic perfusion against an elevated systemic
vascular resistance. The ductus arteriosus becomes unnec-
essary as a pulmonary bypass conduit, and typically closes
within 1 to 3 days in the presence of physiologic PaO2. If a
4.5-mm end-arterial stent is placed in the newborn ductus
arteriosus, increased flow from systemic to pulmonary cir-
cuits will result as soon as pulmonary vascular resistance
falls.
As a result of this increased volume load on the left
ventricle, progressive dilation occurred with compensatory
LV wall hypertrophy. Figure 2 shows representative two-
dimensional transthoracic short-axis echocardiograms from
control (A) and hypertrophied (B) hearts at three weeks of
age. These end-diastolic frames clearly reveal significant LV
chamber dilation. Patency of the ductus arteriosus was
notable both on auscultation and during echocardiography
by color-flow Doppler mapping (not shown) or by contrast
injection (Fig. 2, C). Postmortem examination of the aortic
isthmus and ductus after animal sacrifice was conducted in
all sacrificed animals, revealing full patency of the ductus in
all stented animals (Fig. 2, D), and complete closure in all
control animals.
The morphometric and cardiac structural features of
these animals are summarized in Table 1. Animal weight
increased from 1.52 kg at birth to 3.82 kg at three weeks in
control animals but to only 2.49 kg at three weeks in those
with volume overload hypertrophy, a significant difference
of about 80%. Significant increases in resting heart rate
(from 168 6 3 to 196 6 5 beats/min) and respiratory rate
(from 54 6 3 to 63 6 2 resp/min) were noted in the stented
animals, in accordance with the expected elevation in
pulmonary blood flow via the left to right shunt.
Echocardiographic assessment revealed no substantial
increases in the absolute thickness of the LV, RV or septal
wall thickness in either systole or diastole. Left ventricular
end-diastolic dimension rose from 24.8 6 3.3 to 35.2 6
3.3 mm (p , 0.05) and weight-indexed LV end-diastolic
volume increased from 3.9 6 0.6 to 11.5 6 2.9 ml/kg (p ,
0.05). This resulted in a near doubling of the calculated
mean LV mass from 30.5 6 8 to 56.6 6 11 g and an
increase in the indexed LV mass from 7.3 6 1.3 to 24.3 6
4.3 g/kg (p , 0.05). Hence there was a significant increase
in LV wall mass in the context of ventricular volume
overload in this model.
Maturation of ACC and AMPK activity in fetal, new-
born and three-week old piglets. Table 2 shows the ACC
activity in LV and RV myocardium of fetal, newborn and
three-week old pigs. Data are presented as the basal in vitro
activity of each enzyme, as well as the maximally stimulated
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activity. The latter is measured by the addition in vitro of
high concentrations of citrate (10 mmol/liter) in the case of
ACC. The 2citrate/1citrate ratio thus indicates the pro-
portion of total achievable ACC activity levels in any given
heart, currently being employed without any change in the
phosphorylated state of the ACC.
Similarly, in the case of AMPK, we measured basal
AMPK activity and determined the degree by which 200
mmol/liter AMP was able to allosterically activate AMPK,
as an index of total measurable enzyme capacity without
altering the phosphorylation state of AMPK.
Maximal ACC activity was encountered in the late fetal
phase, where LV ACC activity measured in the absence of
citrate was 536 6 25 pmol/mg/min decreasing to 274 6 30
just after birth, and falling further to 115 6 12 at three
weeks of age (p , 0.05). Right ventricular myocardial values
displayed a similar trend during this time course, although
fetal RV ACC activity was significantly lower than that of
the LV. Malonyl CoA levels in these hearts (Table 3) show
a corresponding trend, with high levels evident in the fetal
LV and RV. These relatively high levels of malonyl CoA are
maintained into early postnatal life, but by three weeks of
age a dramatic decrease in malonyl CoA levels has occurred
corresponding to the drop in ACC activity seen at that time.
Data displayed in Table 2 also reveal that citrate stimu-
lation of myocardial ACC activity resulted in the highest
activity levels in the fetal left and right ventricle, with a
decline in the 2citrate/1citrate ratio being evidenced after
birth. However, maximal activity of well over 300% above
unstimulated levels is still attainable at 3 weeks of age.
These data indicate a rapid maturational decrease in basal
ACC activity occurring in the pig heart just after birth, and
are in accordance with data derived from newborn rabbit
hearts (4).
Our findings indicate higher levels of ACC activity in the
fetal LV than in the newborn animal, which has not
previously been reported. In addition, we were able to show
considerably greater activity in the fetal LV than the fetal
RV. The significance of this unexpected finding is uncer-
tain, given that fetal LV and RV malonyl CoA levels (Table
3) do not differ significantly, but may indicate that the
differences between right and left ventricle extend beyond
anatomic and hemodynamic function alone (19) to involve
regulation of energy metabolism as well.
We also determined what changes occur in AMPK
activity in fetal, newborn and three-week old pig hearts
(Table 2). 59-Adenosine monophosphate–activated protein
kinase activity was highest in fetal hearts, and dropped at
Figure 2. Transthoracic echocardiography of control (A) and stented (B) animals displaying gross dilation of the left ventricle, and
accompanying left ventricular (LV) wall thickening. (C) Aortic root angiogram confirms the ductal flow from the descending aorta to the
pulmonary circulation immediately after stent placement. (D) Explanted specimen showing the juxtaductal aorta and patent (stented)
ductus arteriosus. RV 5 right ventricular.
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birth, an observation similar to the changes seen in newborn
rabbit hearts (4). As expected, a maturational increase in
AMPK activity was observed between newborn hearts and
three-week old hearts, with a rise in activity from 281 6 28
to 488 6 35 pmol/mg/min, an increase of over 70%. The
timing of this increase in AMPK activity corresponds with
the decrease in ACC activity observed during the newborn
period. We noted also that the ratio of 2AMP/1AMP
AMPK activity changed relatively little, suggesting that
increased activity levels result from a change in AMPK
expression at this time, rather than an alteration in AMPK
activation (such as by direct phosphorylation of the en-
zyme).
Interestingly, AMPK activity was higher in the fetal LV
(but not the fetal RV) than the levels seen in newborn heart,
and thus cannot directly explain why levels of ACC activity
are also highest in the fetal LV.
The effect of volume overload hypertrophy on ACC and
AMPK activity. Malonyl CoA levels measured in the LV
and RV from hypertrophied hearts were markedly different
from control animals, as seen in Table 3. Instead of
declining to levels of 35% to 50% of those in the newborn,
they remained elevated, similar to those seen in fetal life.
This finding may be explained by the effect of volume
overload cardiac hypertrophy on LV and RV ACC activity
as shown in Figure 3. Compared with three-week control
hearts, we noted a marked increase in LV ACC activity in
the hypertrophied hearts (115 6 12 vs. 270 6 50 pmol/mg/
min respectively, p , 0.05). Similar results were observed in
the RV. These values obtained in three-week old hypertro-
phied hearts approximated values obtained in the newborn
heart, suggesting a delay in the maturational decrease of
myocardial ACC activity, and therefore persistently elevated
myocardial malonyl CoA levels in the presence of hypertro-
phy.
The effect of cardiac hypertrophy on LV and RV AMPK
activity is shown in Figure 4. In the case of AMPK activity,
we once again noted changes in activity to levels reminiscent
of those in the newborn animal. Left ventricular AMPK
activity was lower in hypertrophied hearts compared with
three-week control hearts (348 6 51 to 488 6 35 pmol/
mg/min, respectively, p , 0.05). A similar decline in
AMPK activity was also seen in the RV.
5*-Adenosine monophosphate–activated protein kinase
and ACC expression in the newborn left ventricle. The
maturational changes in ACC activity may conceivably be
explained by altered expression of the enzyme. Similarly, it
is possible that hypertrophy may alter enzyme expression,
causing the changes in ACC and AMPK activity seen in
three-week old hypertrophied hearts. To determine the
origin of the increase in ACC activity, we performed an
evaluation of ACC expression by Western immunoblotting
with peroxidase-labeled Streptavidin and densitometric
scanning (Fig. 5). As has been described in both the rat and
the rabbit heart, ACC is expressed in porcine myocardium
predominantly as a 280-kDa isoform, with smaller amounts
of a 265-kDa isoform also seen. We were unable to
demonstrate any significant difference in the isoform distri-
bution of ACC in the myocardium before or after birth.
Apart from a transient decrease in the 280-kDa ACC
isoform expression in newborn hearts, total enzyme expres-
sion was not significantly altered, and specifically did not
Table 1. Morphometric and Echocardiographic Measures of Control and Volume Overload
Hypertrophy Animals at Three Weeks of Age
Measures
Three-
Week
Controls
Three-
Week
Hypertrophy
p
Value
Birthweight (g) 1,523 6 81 1,520 6 154 NS
3-week weight (g) 3,823 6 554 2,487 6 305 0.06
% weight gain 144 6 25 63 6 15 0.02
Heart rate (beats/min) 168 6 3 196 6 5 , 0.01
Respiratory rate (breaths/min) 54 6 3 63 6 2 0.02
Interventricular septum (mm) 5.7 6 0.4 6.7 6 0.4 0.11
RV free wall (mm) 4.2 6 0.5 5.9 6 0.7 0.10
LV free wall (mm) 5.1 6 0.5 5.0 6 0.7 NS
LV end-diastolic diameter (mm) 24.8 6 3.3 35.2 6 3.3 0.04
LV end-systolic diameter (mm) 17.5 6 2.7 25.1 6 2.8 0.07
LV shortening fraction (%) 0.31 6 0.03 0.29 6 0.03 NS
LV end-diastolic volume (ml) 19.1 6 5.3 36.6 6 9.7 0.05
LV end-systolic volume (ml) 7.5 6 2.1 10.8 6 2.7 NS
Stroke volume index (ml/kg) 1.6 6 0.2 4.5 6 0.7 0.001
LV mass index (Simpson) (g/kg) 5.4 6 0.6 14.23 6 2.5 0.002
LV mass index (Devereux) (g/kg) 7.3 6 1.3 24.3 6 4.3 0.001
Data are group means 6 SEM of eight and nine hearts in each group. All dimensions are measured in diastole except where
specified. Significance determined by Student t test.
LV 5 left ventricular; RV 5 right ventricular.
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show any significant difference when comparing control or
hypertrophied left ventricles. Clearly ACC expression does
not correlate closely with measured activity of this enzyme
in this setting.
The foregoing suggests that the changes in ACC activity
as observed in the fetal, newborn and three-week old hearts
are determined by posttranslational regulation of the en-
zyme product (i.e., differences phosphorylation or allosteric
regulation of ACC). A role for ACC phosphorylation by
AMPK is supported by the AMPK activity data shown in
Figure 4.
To further characterize the nature of the changes in
AMPK activity seen in the postnatal period, we performed
Western immunoblot studies on the 6% PEG extract from
LV myocardial tissue samples (Fig. 6). 59-Adenosine mono-
phosphate–activated protein kinase expression (as depicted
graphically from measurements of the 63-kDa band density)
increased rapidly after birth, and remained elevated at 3
weeks of age in control animals. However, this increase in
AMPK expression was not present in 3-week old hypertro-
phied hearts, suggesting that hypertrophy delays or reverses
the normal expression of AMPK after birth.
DISCUSSION
Regulation of myocardial fatty acid oxidation in the
newborn period. 59-Adenosine monophosphate–activated
protein kinase is the central component of a protein kinase
cascade that operates by phosphorylation-inhibition of key
regulatory enzymes in various biosynthetic and metabolic
pathways in many tissues (20). In the heart, AMPK is also
highly expressed and has been shown to be an important
regulator of fatty acid oxidation (15).
We have shown that AMPK expression and AMPK
activity increase in the newborn pig heart at the time of
increased exposure to circulating free fatty acid substrate
(suckling), and that this increase is maintained through early
growth, as in other mammalian species (4). As a conse-
quence we have demonstrated that increasing AMPK ac-
tivity will inhibit ACC, lowering levels of malonyl CoA by
Table 2. Acetyl Coenzyme Carboxylase (ACC) and 59-Adenosine Monophosphate–Activated
Protein Kinase (AMPK) Activity in Fetal, Newborn and Three-Week Old Pig Hearts
Fetal Newborn
Three-Week
Control
Left ventricle
ACC activity (pmol/min/mg)
2Citrate 536 6 25 274 6 30 115 6 12
1Citrate 1,004 6 56 639 6 22 475 6 59
2Citrate/1citrate ratio 0.54 6 0.04 0.45 6 0.06 0.25 6 0.02
AMPK activity (pmol/min/mg)
2AMP 462 6 22 281 6 28 488 6 35
1AMP 1,314 6 94 1,100 6 103 1,703 6 117
2AMP/1AMP ratio 0.36 6 0.03 0.26 6 0.02 0.28 6 0.02
Right ventricle
ACC activity (pmol/min/mg)
2Citrate 303 6 30 282 6 45 133 6 22
1Citrate 867 6 63 728 6 34 434 6 38
2Citrate/1citrate ratio 0.36 6 0.04 0.38 6 0.05 0.29 6 0.03
AMPK activity (pmol/min/mg)
2AMP 380 6 18 324 6 29 554 6 47
1AMP 1,179 6 105 1,436 6 23 2,163 6 163
2AMP/1AMP ratio 0.33 6 0.02 0.25 6 0.01 0.25 6 0.01
Acetyl coenzyme A carboxylase activity was measured in the presence or absence of 10 mmol/liter citrate; AMPK activity was
measured in the presence or absence of 200 mmol/liter adenosine monophosphate (AMP). Data are group means 6 SEM of 8
to 11 hearts in each group. Significant differences are indicated in the text, and are determined by analysis of variance with the
Neuman-Keuls post hoc test.
Table 3. Malonyl Coenzyme A levels (nmol/g dry weight) in Fetal, Newborn and Three-Week
Old Control and Hypertrophied Pig Hearts
Fetal Newborn
Three-Week
Control
Three-Week
Hypertrophy
Left ventricle 40.8 6 5.9 49.1 6 5.2 14.4 6 1.1 40.8 6 6.7*
Right ventricle 45.3 6 3.6 29.9 6 3.1 15.8 6 1.3 40.3 6 6.2*
Data are mean 6 SEM of six hearts in each group. *p , 0.05 vs. control (analysis of variance).
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three weeks of age in this model, and facilitating the
transition to free fatty acid oxidation as the main source of
energy for the heart. This regulatory mechanism is partic-
ularly important after the newborn period (Fig. 1). At this
time the heart makes a dramatic transition from using
glucose and lactate as primary fuels, to using fatty acids as
the primary energy source (6). Under normal circumstances
this maturational shift persists throughout life.
Interaction of ACC and AMPK. Our data do not explain
the presence of relatively high levels of AMPK activity in
the fetal heart, while ACC activity and malonyl CoA levels
are also high, and thus presumably not inhibited by AMPK.
We speculate that this may be explained by altered sensi-
tivity of ACC to AMPK-mediated phosphorylation in the
fetal heart; AMPK is a heterotrimeric enzyme complex
whose activity is greatly enhanced by the presence of the
beta subunit (21). This subunit is subject to posttransla-
tional modification in the form of fatty acid myristoylation
and also kinase-mediated phosphorylation (Fig. 1) (22).
These modifications regulate intracellular targeting of
AMPK to specific subcellular membrane sites of activity, as
well as interactions with other enzyme species. The role of
AMPK in the fetal heart may thus be directed to regulate
other aspects of energy metabolism in the absence of
significant fatty acid substrate, by a variety of mechanisms,
explaining the coexisting high levels of AMPK and ACC
activity. The presence of high levels of cardiac malonyl CoA
in the immediate newborn period is also expected, but
appears to lag behind the maturational decrease in ACC
activity which is already evident. It must be recognized that
malonyl CoA levels are determined not only by their rate of
Figure 3. Acetyl coenzyme A (CoA) carboxylase activity mea-
sured in the cytosolic fraction of left ventricular (LV) and right
ventricular (RV) myocardial tissue of newborn pigs, 3-week old
control pigs and 3-week old pigs with volume overload hypertro-
phy. Data are mean 6 SEM of 8 to 10 animals. *p , 0.05
(hypertrophy vs. control) (analysis of variance).
Figure 4. 59-Adenosine monophosphate (59-AMP)–activated
protein kinase activity measured in the cytosolic fraction of left
ventricular (LV) and right ventricular (RV) myocardial tissue from
newborn pigs, 3-week old control pigs, and 3-week old pigs with
volume overload hypertrophy. Data are mean 6 SEM of 8 to 10
animals. *p , 0.05 (hypertrophy vs. control) (analysis of variance).
Figure 5. Expression of acetyl coenzyme A (CoA) carboxylase
(ACC) in left ventricular (LV) myocardium of fetal pigs, newborn
pigs, 3-week old control pigs and 3-week old pigs with volume
overload hypertrophy. Inset shows a representative Western trans-
fer of the 265- and 280-kDa fractions comprising cardiac ACC,
probed with peroxidase-labeled Streptavidin. Densitometric anal-
ysis is expressed as a percentage of expression in fetal LV
myocardium, with the mean in each group determined from 6 to
14 individual hearts each analyzed once. C 5 control; F 5 fetal;
H 5 hypertrophy; Nb 5 newborn. *p , 0.05 (newborn vs. fetal)
(analysis of variance).
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production by ACC, but also by their rate of degradation by
malonyl CoA decarboxylase (23), and further studies will be
required to completely characterize this metabolic transition
in the newborn heart.
The effect of ventricular volume overload. Our data also
describe the effect of volume overload hypertrophy during
the newborn period on this developmental process. We
demonstrate a delay in the maturational increase in AMPK
expression and activity, leading to persistently elevated levels
of ACC activity, and elevated malonyl CoA levels as a
result. This implies that the hypertrophied myocardium is
less able to effectively make the transition from
carbohydrate-based to free fatty acid–based fuels in the
newborn period.
Substantial evidence exists that myocardial metabolism is
fundamentally altered in conditions of myocardial hypertro-
phy in the mature heart. Myocardial aerobic glycolysis and
lactate oxidation increase (10), and both glucose and fatty
acid oxidation rates decrease (9,10), in the latter case
correlating with both the presence and the severity of
hypertrophy. These events represent a regression to a “fetal”
pattern of energy metabolism, since the fetal heart is
primarily reliant on glycolysis and lactate oxidation (24).
Using a clinically relevant model of volume loading with
hypertrophy, we have shown important changes in the
maturation of cardiac energy metabolism after birth. Myo-
cardial AMPK activity does not rise, and ACC activity
remains elevated; malonyl CoA levels are therefore persis-
tently elevated, and the transition to fatty acid energy
sources is impaired.
Clinical relevance. These findings become relevant in the
setting of congenital heart disease in the newborn period,
where left ventricular volume overload is frequently encoun-
tered as a feature of left to right shunt lesions (25), as well
as more complex cardiac defects (26). In this setting, as
dilation and hypertrophy progress, function is measurably
impaired and the mortality and morbidity of corrective
surgery in these patients rises, correlating directly with the
degree of preoperative volume overload (27). Although the
precise mechanisms resulting in adverse outcomes for hy-
pertrophied hearts are uncertain, experimental data have
linked changes in myocardial energy metabolism to post-
ischemic recovery in various models of hypertrophy in the
mature heart (28,29).
It is possible that hypertrophy-induced changes in energy
metabolism may contribute to the reduced contractile re-
covery seen in the newborn heart after cardiopulmonary
bypass. A reduction in oxidation rates of fatty acids and
glucose, with increased anaerobic glycolysis (as is typical of
the “fetal” pattern of myocardial energy metabolism) in
hypertrophied hearts from mature animals has been dem-
onstrated to worsen their response to an ischemic injury and
mechanical performance in the reperfusion phase (30). This
probably results from the excess accumulation of glycolytic
by-products during ischemia (31). Ascuitto et al. have
shown an increased reliance on fatty acid oxidation in the
neonatal pig heart after hypothermic arrest and reperfusion
(32). Further studies are thus required to document the
response to ischemia and reperfusion in the immature
hypertrophied heart.
Limitations of this study. In our model, a left to right
shunt at systemic pressure imposes a volume load on the LV
and a pressure load on the RV (Coe, unpublished data).
Coincident with the adaptive hypertrophy of the LV,
evidence of congestive heart failure was also noted. We have
not determined which of these events specifically results in
the metabolic changes occurring. Also, we have not at-
tempted to characterize the cellular or ultrastructural nature
of the hypertrophy in this model, relying instead upon
echocardiographic measures of ventricular volume and mass
which have previously been validated in humans. We
assume that this volume-overloaded state is relevant to
clinical disease entities of volume overload. There may
however be differences between the cellular pathology of
this model and that of the human equivalent. Further
studies will be required to clarify these issues.
Figure 6. Expression of 59-adenosine monophosphate–activated
protein kinase (AMPK) (alpha2 subfraction) in left ventricular
myocardium of fetal, newborn, 3-week old control and volume-
overloaded animals. Inset shows a representative Western transfer,
probed with ovine raised anti-alpha2AMPK antibodies demon-
strating the 63-kDa region comprising cardiac AMPK. Densito-
metric analysis is expressed as a percentage of expression in fetal
LV myocardium with the mean in each group determined from 6
to 14 individual hearts each analyzed once. Abbreviations as in
Figure 5. *p , 0.05, newborn and control vs. fetal; †p , 0.05,
hypertrophy vs control (analysis of variance).
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In our study, the stented animals failed to grow normally,
due either to inadequate calorie intake and absorption, or to
increased energy expenditure through work of breathing.
Since severe calorie deprivation can independently alter the
status of enzymes involved in fatty acid metabolism in
various tissues including the heart (33), inadequate fatty acid
supply to the heart in the stented piglets may in theory have
modified the effect of mechanical loading on cardiac me-
tabolism. Studies in rats, however, have demonstrated a
decrease in ACC messenger ribonucleic acid transcription
in liver and in heart (34), but no change in protein
expression or activity (32) in skeletal muscle after a 48-h
fast. In contrast, our data reveal an increase in ACC activity
in the heart of the stented animal with no change in enzyme
expression. We have previously noted a decrease in malonyl
CoA levels in the hearts of calorie-deprived rats (unpub-
lished data), but see an increase in cardiac malonyl CoA in
this model. These findings, together with the fact that we
observed normal feeding activity and some weight gain in
the stented animals, suggest that calorie deficiency has little
role in the changes demonstrated in the hearts of these
animals with volume overload hypertrophy.
We have not directly measured rates of fatty acid oxida-
tion or glucose oxidation and glycolysis in this model.
However, published data describe a significant increase in
palmitate oxidation rates in neonatal pig hearts (36) as well
as a reliable inverse correlation between fatty acid oxidative
rates and ACC activity/malonyl CoA levels in the hearts of
various animal models (2,3).
Summary. In this report we utilize a clinically relevant
model of volume-overloaded left ventricular hypertrophy of
the newborn pig heart. We describe the early changes in
some of the regulatory enzymes for cardiac fatty acid
metabolism during the fetal and newborn period under
normal and volume-overloaded conditions. Volume over-
load hypertrophy is seen to delay the normal maturational
decrease in acetyl CoA carboxylase activity in the absence of
changes in enzyme expression. Our findings suggest that
this is due to diminished expression and activity in these
hearts. These findings imply a delay in the normal transition
from carbohydrate- to fatty acid–based fuels in the hyper-
trophied newborn heart. This delay may effect the response
of such hearts to ischemic injury such as that incurred
during cardiopulmonary bypass.
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